These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9620058)
1. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease. Higuchi S; Muramatsu T; Arai H; Hayashida M; Sasaki H; Trojanowski JQ J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):107-13. PubMed ID: 9620058 [TBL] [Abstract][Full Text] [Related]
2. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms. Nanko S; Ueki A; Hattori M; Dai XY; Sasaki T; Fukuda R; Ikeda K; Kazamatsuri H Am J Med Genet; 1994 Dec; 54(4):361-4. PubMed ID: 7726209 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. Manki H; Kanba S; Muramatsu T; Higuchi S; Suzuki E; Matsushita S; Ono Y; Chiba H; Shintani F; Nakamura M; Yagi G; Asai M J Affect Disord; 1996 Sep; 40(1-2):7-13. PubMed ID: 8882909 [TBL] [Abstract][Full Text] [Related]
4. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease. Paus S; Seeger G; Brecht HM; Köster J; El-Faddagh M; Nöthen MM; Klockgether T; Wüllner U Mov Disord; 2004 Jun; 19(6):705-7. PubMed ID: 15197713 [No Abstract] [Full Text] [Related]
5. Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker. Juyal RC; Das M; Punia S; Behari M; Nainwal G; Singh S; Swaminath PV; Govindappa ST; Jayaram S; Muthane UB; Thelma BK Neurogenetics; 2006 Nov; 7(4):223-9. PubMed ID: 16816977 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Planté-Bordeneuve V; Taussig D; Thomas F; Said G; Wood NW; Marsden CD; Harding AE Neurology; 1997 Jun; 48(6):1589-93. PubMed ID: 9191771 [TBL] [Abstract][Full Text] [Related]
7. Variability and validity of polymorphism association studies in Parkinson's disease. Tan EK; Khajavi M; Thornby JI; Nagamitsu S; Jankovic J; Ashizawa T Neurology; 2000 Aug; 55(4):533-8. PubMed ID: 10953187 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease. Wang J; Zhao C; Chen B; Liu ZL Neurosci Lett; 2004 Jan; 355(3):193-6. PubMed ID: 14732464 [TBL] [Abstract][Full Text] [Related]
10. Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects. Li T; Liu X; Zhao J; Hu X; Ball DM; Loh el-W; Sham PC; Collier DA Am J Med Genet; 2002 Apr; 114(3):329-35. PubMed ID: 11920858 [TBL] [Abstract][Full Text] [Related]
11. The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients. Lin JJ; Yueh KC; Chang DC; Chang CY; Yeh YH; Lin SZ J Neurol Sci; 2003 May; 209(1-2):87-92. PubMed ID: 12686408 [TBL] [Abstract][Full Text] [Related]
13. Association of the dopamine transporter gene with Parkinson's disease in Korean patients. Kim JW; Kim DH; Kim SH; Cha JK J Korean Med Sci; 2000 Aug; 15(4):449-51. PubMed ID: 10983695 [TBL] [Abstract][Full Text] [Related]
14. Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found. Mercier G; Turpin JC; Lucotte G J Neurol; 1999 Jan; 246(1):45-7. PubMed ID: 9987713 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D3 and D4 receptor gene polymorphisms and Parkinson's disease. Nanko S; Hattori M; Ueki A; Ikeda K Lancet; 1993 Jul; 342(8865):250. PubMed ID: 8100976 [No Abstract] [Full Text] [Related]
16. Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson's disease in a Chinese population. Wan DC; Law LK; Ip DT; Cheung WT; Ho WK; Tsim KW; Kay R; Woo J; Pang CP Mov Disord; 1999 Mar; 14(2):225-9. PubMed ID: 10091613 [TBL] [Abstract][Full Text] [Related]
17. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Szekeres G; Kéri S; Juhász A; Rimanóczy A; Szendi I; Czimmer C; Janka Z Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):1-5. PubMed ID: 14681904 [TBL] [Abstract][Full Text] [Related]
18. Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases. Fujiwara Y; Yamaguchi K; Tanaka Y; Tomita H; Shiro Y; Kashihara K; Sato K; Kuroda S Eur Neurol; 1997; 38 Suppl 1():6-10. PubMed ID: 9276194 [TBL] [Abstract][Full Text] [Related]
19. Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder. Hamilton SP; Haghighi F; Heiman GA; Klein DF; Hodge SE; Fyer AJ; Weissman MM; Knowles JA Am J Med Genet; 2000 Jun; 96(3):324-30. PubMed ID: 10898909 [TBL] [Abstract][Full Text] [Related]
20. [Association between dopamine transporter gene polymorphism and Parkinson's disease]. Zhang L; Shao M; Xu Q; Dong X; Yang J; Li Y; Chen B Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):431-4. PubMed ID: 11774209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]